Zimbabwe has rejected a major US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for confidential information.
This move came to light following a official document dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson has since explained that the United States was requesting health data for scientific study and commercial gain while refused to share the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for continued talks to reach a agreement agreeable to both sides so the nation's critical HIV treatment initiative can continue.
Broader Implications
This development comes after a comparable case in Kenya, where a court suspended a similar deal with the US after legal challenges were raised about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump claimed its spending was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and accountability.
As per reports, 16 African countries have so far signed these new health pacts, constituting over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our country would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be available to our people if a new disease outbreak arise."
National Interest and International Frameworks
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting systems previously set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This mechanism is intended to ensure that when a nation contributes its information, the benefits – including medicines and cures – are shared equitably, not monopolised solely by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We welcome further discussions with our US partners on how future collaboration could be structured in a manner that honours the sovereignty and interests of both nations."
Health Experts Response
A leading public health body expressed it recognised the government's concerns, but suggested that talks should continue since a large portion of the nation's HIV programmes depended on international support.
"In cases where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
The situation emphasises the continuing debate between accepting vital international aid and safeguarding national sovereignty in an increasingly interconnected world.